Physician

Radhika Rajsheker, MD

According to 2025 Medicare claims, Radhika Rajsheker, MD (NPI: 1417134834) practices hematology/oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Butler, OH. This provider's primary affiliated billing organization is DAYTON PHYSICIANS, LLC (NPI: 1902844947; TIN: 203130844) and primary practice location at 45005-5165.

Rajsheker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 453 traditional Medicare patients, billed 99,585 HCPCS/CPT codes, and received $1,027,782 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,898 prescription claims across 311 beneficiaries totaling $4,640,356 in drug costs, led by Revlimid (Lenalidomide). DME data shows 24 claims. Open Payments data shows 144 records totaling $3,130. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $78,437 to $4,640,356. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,180 to $2,711.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	109	8,541	$103,234
2016	359	73,589	$705,017
2017	400	88,521	$880,585
2018	467	106,672	$1,459,083
2019	470	120,742	$1,666,392
2020	473	96,340	$1,350,674
2021	458	96,203	$1,216,062
2022	451	85,342	$1,069,640
2023	503	111,436	$1,296,217
2024	453	99,585	$1,027,782

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	101	306	$78,437
2016	285	1,875	$730,273
2017	301	2,154	$1,271,205
2018	271	1,786	$1,841,092
2019	253	1,717	$1,807,687
2020	237	1,764	$2,765,256
2021	282	1,905	$3,061,000
2022	324	1,875	$2,525,094
2023	300	1,641	$4,501,686
2024	311	1,898	$4,640,356

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	24	$1,076
2018	N/R	N/R	N/R
2019	N/R	23	$3,155
2020	N/R	41	$3,162
2021	N/R	36	$2,136
2022	N/R	62	$1,700
2023	N/R	25	$4,453
2024	N/R	24	$1,009

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	163	386	$91
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	74	218	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	237	367	$62
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	78	163	$43
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	326	809	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	36	994	$754,861
Lenalidomide	Lenalidomide	43	1,106	$613,341
Tasigna	Nilotinib Hcl	23	644	$449,714
Ibrance	Palbociclib	27	756	$406,125
Jakafi	Ruxolitinib Phosphate	19	630	$327,642

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$827
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$182

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	144	$3,130	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Radhika Rajsheker, MD?

Tedicare shows public-source Medicare data for Radhika Rajsheker, MD (NPI 1417134834), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Radhika Rajsheker, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Radhika Rajsheker, MD?

Radhika Rajsheker, MD is linked to DAYTON PHYSICIANS, LLC (billing NPI 1902844947) in the available physician profile data.

Does Radhika Rajsheker, MD have Open Payments data?

Radhika Rajsheker, MD has 144 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.